DocumentCode
171175
Title
Functionalized nanophase hydroxyapatite (HA) for orthopedic applications
Author
Bhardwaj, Garima ; Webster, Thomas J.
Author_Institution
Dept. of Chem. Eng., Northeastern Univ., Boston, MA, USA
fYear
2014
fDate
25-27 April 2014
Firstpage
1
Lastpage
2
Abstract
Orthopedic implants fail due to various reasons such as extensive bacterial colonization, poor osseointegration, extensive inflammation and osteolysis due to wear debris. In order to reduce orthopedic implant failures, the main objective of this study was to create a biomimetic bone tissue engineering material based on the osteoconductive properties of nanophase hydroxyapatite (HA), the bacterial inhibition properties of the MAM7 peptide1, the quorum sensing inhibitor RNAIII peptide2, and the anticancer properties of the PCK3145 peptide3 as well as curcumin4. Results showed promise for these materials to combat common failure modes of orthopedic implants.
Keywords
RNA; antibacterial activity; bioceramics; biomimetics; bone; calcium compounds; cancer; failure (mechanical); nanomedicine; orthopaedics; prosthetics; tissue engineering; wear; HA; MAM7 peptide1; PCK3145 peptide; anticancer properties; bacterial inhibition properties; biomimetic bone tissue engineering material; common failure modes; curcumin; extensive bacterial colonization; extensive inflammation; functionalized nanophase hydroxyapatite; orthopedic applications; orthopedic implant failures; orthopedic implants; osseointegration; osteoconductive properties; osteolysis; quorum sensing inhibitor RNAIII peptide; wear debris; Adhesives; Implants; Microorganisms; Nanoparticles; Peptides; Plasmas; Surface treatment; Hydroxyapatite(HA); MAM7; PCK3145; RNAIII peptide; curcumin;
fLanguage
English
Publisher
ieee
Conference_Titel
Bioengineering Conference (NEBEC), 2014 40th Annual Northeast
Conference_Location
Boston, MA
Type
conf
DOI
10.1109/NEBEC.2014.6972730
Filename
6972730
Link To Document